Background In a previous meta-analysis, we identified a survival benefit from neoadjuvant
chemotherapy or chemoradiotherapy before surgery in patients with resectable …

Objective: This network meta-analysis compared overall survival after neoadjuvant or
adjuvant chemotherapy (CT), radiotherapy (RT), or combinations of both …

Importance The prognosis of patients with locally advanced esophageal squamous cell
carcinoma (ESCC) remains poor after surgery. Neoadjuvant chemoradiotherapy (NCRT) …

Purpose The efficacy of neoadjuvant chemoradiotherapy (NCRT) plus surgery for locally
advanced esophageal squamous cell carcinoma (ESCC) remains controversial. In this trial …

The primary objective of these guidelines is to provide general clinicians with information
that would guide them to make informed choices of the available diagnosis/treatment …

PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical
decision making for patients with locally advanced esophageal cancer. METHODS ASCO …

Background The role of neoadjuvant chemoradiotherapy in the treatment of patients with
esophageal or esophagogastric-junction cancer is not well established. We compared …

Background Resectable oesophageal cancer is often treated with surgery alone or with
preoperative (neoadjuvant) chemoradiotherapy or chemotherapy. We aimed to clarify the …

INTRODUCTION: Preoperative chemotherapy (CT) and preoperative chemoradiation
therapy (CRT) for resectable oesophageal cancer have been shown to improve overall …

Traditionally, surgery is considered the best treatment for oesophageal cancer in terms of
locoregional control and long-term survival. However, survival 5 years after surgery alone is …